Health & Fitness

According to FutureWise analysis the market for mobility aid devices in 2026 is US$ 8.63 billion, and is expected to reach US$ 14.12 billion by 2036 at a CAGR of 5.05%. The growth is fueled by an aging population, increased mobility-limiting conditions, and a focus on rehabilitation and long-term care. Advances in ergonomic design, lightweight materials, and smart mobility solutions are enhancing adoption in hospitals, homecare, and assisted living facilities. A mobility aid refers to various devices designed to assist individuals with mobility challenges, facilitating walking and other forms of movement. These aids primarily benefit the elderly and disabled, allowing them to navigate their environments more easily. They are also essential for transporting patients who have limited mobility, especially in home care settings. Common examples of mobility aids include braces, canes, crutches, and walkers. Specifically, walking aids, which encompass assistive canes (also known as walking ... Continue reading →

According to FutureWise analysis the market for Mobility Aids and Transportation Equipment in 2026 is US$ 7.10 billion, and is expected to reach US$ 12.97 billion by 2036 at a CAGR of 6.21%. The growth is driven by a rising elderly population, more mobility-related disabilities, and greater demand for accessible transportation. Innovations in powered mobility devices, lightweight materials, smart features, and expanding homecare services are further boosting adoption in healthcare and personal mobility. Mobility aids and transportation equipment comprise a wide array of assistive devices aimed at enhancing movement, independence, and accessibility for individuals facing mobility limitations. This category includes a variety of mobility aids such as wheelchairs, walkers, canes, crutches, and mobility scooters. In addition, there are specialized transportation solutions like patient transfer systems, powered wheelchairs, stair lifts, vehicle lifts, and accessible transport platforms. ... Continue reading →

According to FutureWise analysis the market for Mobility Devices in 2026 is US$ 12.84 billion, and is expected to reach US$ 24.26 billion by 2036 at a CAGR of 6.57%. Growth is fueled by the rising elderly population, increasing mobility impairments, and greater adoption of assistive mobility solutions. Advancements in smart technologies, lightweight materials, and user-centric designs, along with expanding homecare and rehabilitation services, are driving market expansion. Mobility devices are essential assistive medical and personal care products designed to support individuals with limited physical movement in maintaining independence, safety, and an active lifestyle. This category encompasses a wide array of solutions, including wheelchairs, walkers, canes, crutches, mobility scooters, and advanced powered mobility systems. They are particularly beneficial for elderly individuals, people with disabilities, and patients recovering from injuries, surgeries, or chronic conditions that ... Continue reading →

According to FutureWise analysis the market for moderate-to-severe acne therapeutics in 2026 is US$ 1.59 billion, and is expected to reach US$ 2.68 billion by 2036 at a CAGR of 5.36%. Market growth is fueled by the rising cases of persistent acne, more dermatology consultations, and increased awareness of early intervention. The development of novel biologics, combination therapies, and personalized treatments, along with better access to dermatology care, supports long-term market expansion. Moderate-to-severe acne therapeutics include a variety of prescription treatments aimed at addressing complex and persistent acne cases that do not adequately respond to over-the-counter options. These conditions often present with widespread inflammatory lesions, nodules, cysts, and are associated with an increased risk of scarring and psychological distress. It is crucial to implement effective therapeutic interventions not only to alleviate symptoms but also to prevent long-term skin damage ... Continue reading →

According to FutureWise analysis the market for Molecular Cytogenetics in 2026 is US$ 3.35 billion, and is expected to reach US$ 7.40 billion by 2036 at a CAGR of 8.25%. Market growth is driven by rising demand for advanced genetic diagnostics, increased prevalence of cancer and genetic disorders, and expanding applications in prenatal and oncology testing. Advancements in FISH, CGH, and molecular karyotyping technologies, along with greater adoption in clinical labs and research institutions, are also contributing to this expansion. Molecular Cytogenetics is a distinct field within genetics that merges traditional cytogenetic approaches with molecular biology techniques to examine chromosomes with enhanced precision. This discipline is essential for identifying and characterizing chromosomal abnormalities—such as deletions, duplications, translocations, and aneuploidies—that may not be detectable through standard karyotyping methods. By integrating cytogenetics with ... Continue reading →

According to FutureWise analysis the market for molecular diagnostics devices and equipment in 2026 is US$ 29.13 billion, and is expected to reach US$ 58.11 billion by 2036 at a CAGR of 7.15%. Growth is driven by rising adoption of PCR and next-generation sequencing technologies, with increasing demand for early and accurate disease detection. Expanding applications in oncology, infectious diseases, and genetic testing, along with automation and point-of-care innovations, are enhancing the market outlook. The molecular diagnostics market consists of various products and services focused on the diagnosis of infectious diseases through the detection of specific DNA or RNA sequences at the molecular level. These advancements enable healthcare professionals to make more accurate treatment decisions during the early stages of a disease. This market can be categorized into three main segments: instruments, reagents, and consumables. Instruments are the devices used for testing, reagents are ... Continue reading →

According to FutureWise analysis the market for Molecular Breast Imaging in 2026 is US$ 0.92 billion, and is expected to reach US$ 1.56 billion by 2036 at a CAGR of 5.42%. This growth is driven by heightened awareness of early breast cancer detection and the benefits of molecular breast imaging for dense tissue. Advances in gamma camera technology and increased adoption in diagnostic imaging centers also support market expansion. Molecular Breast Imaging (MBI) represents an innovative approach in nuclear medicine, aimed at enhancing the detection and characterization of breast cancer, particularly in women with dense breast tissue where traditional mammography may fall short. Unlike standard imaging techniques that primarily focus on anatomical features, MBI emphasizes functional imaging by highlighting the metabolic activity within breast tissue. This methodology allows healthcare professionals to pinpoint malignant lesions based on their biological behavior, rather than relying ... Continue reading →

According to FutureWise analysis, the Molecular Quality Controls market in 2026 is US$0.24 billion, and is expected to reach US$0.39 billion by 2036 at a CAGR of 4.97%.  The Molecular Quality Controls market is currently witnessing significant growth, primarily driven by the increasing adoption of molecular diagnostics in clinical laboratories. A key factor in this expansion is the heightened emphasis on standardization and accreditation within laboratory practices. Additionally, the rising demand for personalized medicine and companion diagnostics is propelling market development, as quality controls play a vital role in ensuring the accuracy and reliability of molecular testing outcomes. Geographically, North America dominates the market, supported by a robust healthcare infrastructure and stringent regulatory frameworks that prioritize laboratory quality assurance. Within this sector, the oncology segment emerges as a particularly important application area, where molecular ... Continue reading →

According to FutureWise analysis the market for Molecular Diagnostics in 2026 is US$ 19.71 billion, and is expected to reach US$ 41.24 billion by 2036 at a CAGR of 7.66%. The expansion is driven by the rising demand for quick and accurate diagnostic solutions in infectious diseases, oncology, and genetic testing. Advancements in PCR, next-generation sequencing, and automation, along with greater adoption in clinical and point-of-care settings, are fueling market growth. Molecular diagnostics is an important area of medical testing that focuses on the identification and analysis of molecular components, specifically nucleic acids and proteins. This field employs advanced laboratory techniques to detect and quantify specific biomarkers that can indicate the presence of disease or various health conditions. The applications of molecular diagnostics are broad, encompassing the detection of infectious diseases, genetic disorders, and various types of cancers. By thoroughly analyzing the ... Continue reading →

According to FutureWise analysis, the molecular spectroscopy market in 2026 is US$7.67 billion, and is expected to reach US$14.10 billion by 2036 at a CAGR of 6.28%. The molecular spectroscopy market is experiencing significant growth, fueled by increasing applications in pharmaceutical research, environmental monitoring, and food safety testing. Advancements in spectroscopy techniques, such as near-infrared (NIR), Raman, and nuclear magnetic resonance (NMR) spectroscopy, are enhancing analytical capabilities and broadening use cases across various industries. The pharmaceutical and biotechnology sectors represent the largest segments of end-users, utilizing molecular spectroscopy for drug discovery, quality control, and process monitoring. Additionally, increasing investments in research and development, particularly in emerging economies, are creating new opportunities for market expansion. The integration of artificial intelligence and machine learning with spectroscopy ... Continue reading →